Jinzanghuang Tibet Pharmaceuticals, Inc. (JZHG.OB), today announced the financial results for the six months ended December 31, 2011. Net income increased 1019% or $0.08 per basic and diluted earnings per share.

China Modern Agricultural Information Inc. (OTCBB: CMCI), today announced the financial results ended December 31st, 2011. Net income increased 155% to $9.5 million or $0.22 per basic and diluted earnings per share.

Through attending the annual meeting, CMCI has given excellent impressions on cow-breeding companies, and is expected to seek for further development opportunities.

This article sums up the leading factors of Jinzanghuang’s successful business activities in the severe international industrial competition and its outstanding operation results.

Through joining the marketing peak forum, the company’s development model has left profound impressions on potential clients, which will help increase the market share and improve the reputation of the company.

Through the annual exchange meeting held by the corporation, principals of the first and second level companies throughout the nation have got further communications with the corporation, and expressed confidence on the cooperation in future.

Summary: The visit to terminal clients from Jinzanghuang, which has improved the company’s reputation, is expected to expand the marketing effects, and to make further relationships with the clients.

Jinzanghuang Tibet Pharmaceuticals, Inc today announced that they will bring in 7 new types of health products which are made of Tibetan pharmaceutical, upon which, the Company will run 15 kinds of Tibetan pharmaceutical products.

Jinzanghuang announced that their revenues ended June 30, 2011 has reached $3,716,529, increased by 479%, compared to 2010, the net income increased by 2850% to $1,865,988.